Security record · archived quarter
SNN
Smith & Nephew plc · Healthcare · Medical - Devices
4Tracked holders
+1Δ holders
214.49KShares held
$6.68MReported value
+1New positions
−0Exits
All ownership figures: tracked 13F managers only, common-stock positions, reporting period Q3 2024
Ownership over time
| Quarter | Holders | Δ | Shares | Reported value | New | Exits |
|---|---|---|---|---|---|---|
| Q2 2026 | 75 | +1 | 22.17M | $639.71M | +4 | −3 |
| Q1 2026 | 75 | +2 | 19.54M | $620.82M | +5 | −3 |
| Q4 2025 | 73 | 0 | 18.46M | $605.64M | — | — |
| Q3 2025 | 12 | -1 | 6.32M | $229.46M | +1 | −2 |
| Q2 2025 | 10 | +2 | 1.67M | $51.09M | +2 | — |
| Q1 2025 | 6 | 0 | 2.19M | $62.29M | +1 | −1 |
| Q4 2024 | 6 | +1 | 4.19M | $103.01M | +2 | −1 |
| Q3 2024 | 4 | +1 | 214.49K | $6.68M | +1 | — |
| Q2 2024 | 3 | — | 434.31K | $10.76M | — | — |
Who holds it · Q3 2024
| # | Manager | Shares | Δ shares | Value | Their weight | Held | ||
|---|---|---|---|---|---|---|---|---|
| 1 | Bridgewater Associates ✦ | 92.61K | -33.2% | $2.88M | 0.0% | ▼ Trim | 2 | SEC ↗ |
| 2 | Citadel Advisors ✦ | 72.21K | -62.6% | $2.25M | 0.0% | ▼ Trim | 2 | SEC ↗ |
| 3 | D. E. Shaw & Co. ✦ | 37.81K | New | $1.18M | 0.0% | New | 1 | SEC ↗ |
| 4 | Marshall Wace ✦ | 11.86K | -88.5% | $369,383 | 0.0% | ▼ Trim | 2 | SEC ↗ |
“Their weight” = the position's share of that manager's reported 13F equity value — the conviction measure. ✦ = curated manager.
New buyers
| D. E. Shaw & Co. | $1.18M | 0.0% |
Exited
| No tracked exits this quarter. |
Full-market context: across ALL 13F filers (SEC structured data, Q1 2026): 2 holders, 515.19K shares, $4.73M reported. This is a different, older period than the tracked-universe figures above and the two are never mixed.
Frequently co-owned
What else this security's tracked holders most often hold — shared-ownership counts, not fundamental relationships.
Provenance: Ownership from parsed 13F common-stock positions (tracked universe, comparable sets for changes); insider rows from Forms 3/4/5; stakes from Schedules 13D/13G; every filing links to its original on SEC EDGAR.
Reporting period: Q3 2024 ·
Methodology ·
Get this via the API